AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Compare which retirement index funds offer the lowest costs in 2024 and learn how to integrate them into a balanced retirement strategy.
23,813 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Could a billionaire wealth tax really fund more social programs? This guide breaks down the revenue potential, the as...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
President Donald Trump plans up to four in-person talks with Xi Jinping within eight months as Air Force One heads to...
In early 2026, investigators flagged AI-assisted conversations linked to violent acts, prompting urgent questions abo...
A federal judge invalidated the White House’s $100,000 H-1B filing fee, creating immediate uncertainty for U.S. emplo...
The supreme court rules against Trump's bid to fire Lisa Cook at the Federal Reserve, keeping her in place as the cas...
The Virtus InfraCap U.S. Preferred Stock ETF trades near $21 with a 9.9% forward yield built on leverage and high-cou...
The inaugural Fortune-style Crypto 40 lays out who truly moves the crypto economy in 2026, led by Uniswap in DeFi and...
Investing in Broadcom means weighing powerful data-center demand against semiconductor cycles. This guide breaks down...
When a magnificent dividend stock drops 8%, it can feel painful. This guide shows how to separate price swings from l...
Insider activity can be a clue about a company’s path, but the motives are varied. This article dissects iradimed's s...